BUPROPION HYDROCHLORIDE (SR)
- Product NDC
- 71335-0025
- 11-digit product format
- 713350025
- Labeler code
- 71335
- Product ID
- 71335-0025_098f9320-427d-494c-84ae-557715100cf2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bupropion Hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA206674
- Marketing category
- ANDA
- Marketing start
- 2016-07-25
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-0025-1 | 71335002501 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0025-1) | 2017-03-30 | 0000-00-00 | No | No | Current |
| 71335-0025-2 | 71335002502 | 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0025-2) | 2017-03-30 | 0000-00-00 | No | No | Current |
| 71335-0025-3 | 71335002503 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0025-3) | 2017-03-30 | 0000-00-00 | No | No | Current |
| 71335-0025-4 | 71335002504 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0025-4) | 2017-03-30 | 0000-00-00 | No | No | Current |
| 71335-0025-5 | 71335002505 | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0025-5) | 2017-03-30 | 0000-00-00 | No | No | Current |
| 71335-0025-6 | 71335002506 | 28 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0025-6) | 2017-03-30 | 0000-00-00 | No | No | Current |